These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31603988)

  • 1. How and when to use clozapine.
    Rubio JM; Kane JM
    Acta Psychiatr Scand; 2020 Mar; 141(3):178-189. PubMed ID: 31603988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine prescribing barriers in the management of treatment-resistant schizophrenia: A systematic review.
    Baig AI; Bazargan-Hejazi S; Ebrahim G; Rodriguez-Lara J
    Medicine (Baltimore); 2021 Nov; 100(45):e27694. PubMed ID: 34766570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational Characteristics of Veterans Affairs Clinics With High and Low Utilization of Clozapine.
    Gören JL; Rose AJ; Engle RL; Smith EG; Christopher ML; Rickles NM; Semla TP; McCullough MB
    Psychiatr Serv; 2016 Nov; 67(11):1189-1196. PubMed ID: 27301765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
    Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
    Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine: a review of clinical practice guidelines and prescribing trends.
    Warnez S; Alessi-Severini S
    BMC Psychiatry; 2014 Apr; 14():102. PubMed ID: 24708834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescriber and institutional barriers and facilitators of clozapine use: A systematic review.
    Verdoux H; Quiles C; Bachmann CJ; Siskind D
    Schizophr Res; 2018 Nov; 201():10-19. PubMed ID: 29880453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leponex, 10 years after -- a clinical review].
    Llorca PM; Pere JJ
    Encephale; 2004; 30(5):474-91. PubMed ID: 15627052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey.
    Leung JG; Cusimano J; Gannon JM; Milgrom O; Valcourt SC; Stoklosa JB; Kemp M; Olsufka W; Vickery PB; Nichols SD; Crouse EL; Paxos C; Johnson EK; Palmer BA
    Int Clin Psychopharmacol; 2019 Sep; 34(5):247-256. PubMed ID: 31107831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THERE IS ROOM FOR IMPROVEMENT: THE RATE OF CLOZAPINE USE AMONG PATIENTS WITH SCHIZOPHRENIA IN ISRAEL].
    Krivoy A; Hoshen M; Fischel T; Taler M; Segev A; Weizman A
    Harefuah; 2019 Jul; 158(7):449-452. PubMed ID: 31339244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine].
    Inada K; Ishigooka J
    Nihon Rinsho; 2013 Apr; 71(4):678-83. PubMed ID: 23678599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
    Tang Y; Horvitz-Lennon M; Gellad WF; Lave JR; Chang CH; Normand SL; Donohue JM
    Psychiatr Serv; 2017 Jun; 68(6):579-586. PubMed ID: 28196460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review.
    Gillespie AL; Samanaite R; Mill J; Egerton A; MacCabe JH
    BMC Psychiatry; 2017 Jan; 17(1):12. PubMed ID: 28086761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic and clinical variation in clozapine use in the United States.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Psychiatr Serv; 2014 Feb; 65(2):186-92. PubMed ID: 24233347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.